The inhibition of prolactin secretion by 2-bromo-α-ergocryptine (CB 154) has been reported in in vitro studies [4] and in experimental animals [5]. Moreover, Lutterbeck et al. [3] reported suppression of non-puerperal galactorrhoea in three women treated with CB 154. The present communication reports the comparative effects of this drug and of L-dopa on prolactin secretion in a man suffering from galactorrhoea due to a pituitary tumour. Galactorrhoea was evaluated by measuring the amount of milk which could be expressed from the breasts. Human plasma prolactin was measured by a radioimmunoassay previously developed for ovine prolactin [1] and extended to human prolactin [2]. Basal levels of prolactin, ranging from 800 to 1,550 mU/ml, were significantly elevated. A single oral dose of 400 mg L-dopa elicited no significant decrease in prolactin levels. On the contrary, CB 154 (5 mg/day per os) induced within 48 h a significant fall in prolactin levels, reaching normal values (210 mU/ml) after 1 month of treatment. Accordingly, milk production decreased significantly. Placebo had no effect. These data confirm previous observations assessing a direct action of CB 154 on prolactin cells [4], and suggest its usefulness in clinical practice. Acknowledgements We are indebted to Prof. E. Flückiger and to Dr. P. M. Lutterbeck (Sa¤doz Ltd., Basle, Switzerland) for generous gifts of CB 154 and of placebo. Dr. G. D. Niswender kindly provided the reagents used for prolactin assays. Copinschi/L'Hermite/Pasteels/Robyn 129 References Davis, S. L.; Reichert, L. E., and Niswender, G. D.: Serum levels of prolactin in sheep as measured by radioimmunoassay. Biol. Reprod. 4: 145-153 (1971). L'Hermite, M.; Delvoye, P.; Nokin, J.; Vekemans, M., and Robyn, C.: Human prolactin secretion, as studied by radioimmunoassay: some aspects of its regulation; in Griffiths and Boyns : Workshop on prolactin and carcinogenesis pp. 81-97, Alpha Omega Alpha, Cardiff 1972. Lutterbeck, P. M.; Pryor, J. S.; Varga, L., and Wenner, R.: Treatment of non-puerperal galactorrhoea with an ergot alkaloid. Brit. med. J. Hi: 228-229 (1971). Pasteels, J. L.; Danguy, A.; Frerotte, M. et Ectors, F.: Inhibition de la secretion de prolactine par Γergocornine et la 2-Br-α-ergocryptine: action directe sur Γhypophyse en culture. Ann. Endocrin., Paris 32: 188-192 (1971).
